InfectoTest develops point-of-care diagnostic tools that utilize rapid molecular testing techniques to detect infectious diseases directly at the site of patient care. This technology delivers timely and accurate results, enabling healthcare providers to make informed treatment decisions and enhance patient outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Diagnosing periprosthetic joint infections (PJI) typically involves lengthy lab procedures and significant wait times for results. This delay can lead to prolonged patient discomfort, increased healthcare costs, and delayed treatment decisions.
Solution
InfectoTest is developing InfectoSynovia, a point-of-care diagnostic test designed for rapid detection of PJI. The test utilizes an electrochemical analysis method that requires only a small sample of synovial fluid. This allows healthcare providers to obtain accurate results in under 5 minutes, enabling faster and more informed treatment decisions directly at the point of care.
Target Audience
The primary target audience includes healthcare providers specializing in orthopedics and traumatology, particularly those managing patients undergoing or having undergone joint replacement surgery.
Features
- Electrochemical analysis for rapid detection of PJI markers
- Minimal synovial fluid sample required
- Results available in under 5 minutes
- Designed for point-of-care use, eliminating the need for central lab processing